AKT1 and hepatocellular carcinoma: In addition, IQGAP3 interacts with protein kinase C δ (PKCδ) to competitively inhibit the interaction between PKCδ and PKCα, freeing and activating PKCα, and triggering PI3K/AKT signaling pathways to enhance HCC cell proliferation (21).